[1] Liu C W, Zhang Z Y, Wang J Y, et al. Research progress on the biological activities of theaflavins [J]. Food Science, 2022, 43 (19): 38-50. (茶黃素生物學活性研究進展,系統綜述抗氧化、抗炎、抗腫瘤等多效性機制)
[2] Zhang R, Zhang Y H, Zhou J P. Bioactivity, mechanism, and application of theaflavins: a review [J]. Science and Technology of Food Industry, 2025, 46 (10): 1-10. doi: 10.13386/j.issn1002-0306.2024060192. (全面梳理茶黃素在心腦血管、代謝疾病、抗病毒等領域的最新研究與應用前景)
[3] Mhatre S, D'Souza S, Mhatre S. In silico analysis of theaflavins as potential inhibitors of SARS-CoV-2 3CLpro [J]. Journal of Biomolecular Structure & Dynamics, 2021, 39 (17): 6210-6218. (分子對接證實茶黃素可抑制新冠病毒 3CL 蛋白酶,為抗 COVID-19 提供理論依據)
[4] Kudo T, Nakamura T, Ohinata H, et al. Effects of oral theaflavin administration on body composition in healthy humans: a randomized, double-blind, placebo-controlled trial [J]. Journal of Nutrition Science, 2020, 9: e10. (隨機對照試驗證明茶黃素可改善健康人群體脂率、提升骨骼肌占比)
[5] Wang J, Jiang J J, Zhao C Y, et al. The protective effect of theaflavins on the kidney of mice with Type 2 diabetes mellitus [J]. Nutrients, 2022, 14 (15): 3102. (闡明茶黃素通過抑制 AGEs/MAPK/NF-κB 通路改善糖尿病腎病的機制)
[6] Sato T, Tanaka T, Sato M. Antibacterial mechanism of theaflavin against Bacillus coagulans [J]. Food Control, 2019, 101: 215-220. (揭示茶黃素通過改變細胞膜磷脂酰甘油親和力發揮抑菌作用的分子機制)
[7] Anandhan A, Thennarasu K, Guha M, et al. Theaflavin-3,3'-digallate attenuates neuroinflammation and dopaminergic neurodegeneration in a mouse model of Parkinson's disease [J]. Neuropharmacology, 2020, 168: 107965. (證實茶黃素可抑制神經炎癥、保護多巴胺能神經元,為帕金森病干預提供新方向)